In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Focus-logo.png

on Obesity and Cardiovascular Disease

 

The prevalence of obesity has more than doubled over the past four decades and has reached pandemic proportions, with major repercussions on public health. While obesity affects several organs and systems of the human body, two thirds of obesity-related excess mortality is attributable to cardiovascular disease. The recently published “ESC Clinical Consensus Statement on Obesity and Cardiovascular Disease” discusses current evidence on the epidemiology and aetiology of obesity, the interplay between obesity, cardiovascular risk factors and cardiac conditions, the clinical management of patients with cardiac disease and obesity, and weight loss strategies with particular focus on their impact on cardiometabolic risk and cardiac outcomes. 

The content below was selected by Ronen Beeri, Thomas GorterKonstantinos Koskinas, and Emeline Van Craenenbroeck to help you delve into the various aspects of obesity and cardiovascular disease.

 

 

 Webinars

Obesity: epidemiology, diagnosis, and impact on cardiovascular risk
8 January 2025
With Konstantinos Koskinas, Maria Marketou, Annika Rosengren
and Eva Prescott


Obesity management: implications for cardiovascular risk reduction
22 January 2025
With Thomas Gorter, Naveed Sattar and Konstantinos Koskinas



Essentials


Dig deeper

Exclusive for members

 Clinical Case Management: impact of comorbidities on personalised care for hypertension

 Clinical Case Management: aortic stenosis and morbid obesity

 Adherence to Nordic and Mediterranean dietary patterns may be associated with a lower absolute risk of incident atherosclerotic cardiovascular disease

 Metabolic bariatric surgery as first-line therapy to improve outcomes

 GLP-1 RA as first-line therapy to improve outcomes?

 Lifestyle intervention in HFpEF with obesity to improve outcomes

 HFpEF patients with obesity and atrial fibrillation: role of exercise and ablation

 Lifestyle management of hypertension: eat

 HFpEF patient with obesity and exercise intolerance: case presentation

 Weight reduction to improve outcomes after atrial fibrillation ablation in patients with obesity

 Tackling obesity in PCI patients: biological and technical considerations

 The obesity syndemic in the European community: towards a systems thinking approach for preventive policies

 Obesity: an overlooked player in cardiological practice and the need for urgent action

 Aerobic, resistance, or combined exercise training and cardiovascular risk profile in overweight or obese adults: the CardioRACE trial

 Lifestyle interventions to change trajectories of obesity-related cardiovascular risk from childhood onset to manifestation in adulthood: a joint scientific statement of the task force for childhood health of the European Association of Preventive Cardiology and the European Childhood Obesity Group

 Promotion of healthy nutrition in primary and secondary cardiovascular disease prevention: a clinical consensus statement from the European Association of Preventive Cardiology

 Weight loss, bariatric surgery and cardiovascular prevention

 Gut Microbiota and Associated Metabolites Play a Key Role in the Pathogenesis of the Obesity Phenotype of Heart Failure With Preserved Ejection Fraction

 The origins of the obesity epidemic

 We can reduce cardiovascular risk by treating obesity

 The economics of obesity: can we afford to treat it? Can we afford not to?

 Fixing the obesity crisis - discussion

 Exercise intervention in HFpEF patients with obesity

 Dietary intervention in HFpEF patients with obesity

 Optimal medical therapy in HFpEF patients with obesity

 Impact of obesity on acute cardiovascular outcomes

 Anti-obesity medications in the acute setting: when should we start, stop, or continue?

 Evidence for cardio-renal protection through weight reduction

 Atrial fibrillation: obesity matters

 Optimal oral anticoagulation in atrial fibrillation patients with obesity

 Weighty matters! Deciding the best care for atrial fibrillation patients with obesity - discussion

 Preparation, access, and radiation considerations in PCI for patients with obesity

 Post-procedural care for PCI and surgery in patients with obesity

 Weight management before and after cardiac procedures in patients with obesity

 Obesity as a cardiovascular risk factor

 Ectopic fat depots: how to measure them and their impact on cardiovascular risk

 Current approaches to the prevention and management of obesity

 Perivascular adipose tissue: link between obesity, diabetes, and blood pressure

 Imaging of vascular and myocardial adipose tissue: a window to cardiovascular risk prediction

 Burden and disparities in cardiovascular mortality rates associated with obesity prevalence in United States: county-level analysis from 2010 to 2019

 Lifestyle interventions: optimising cardiac energy metabolism by exercise

 Automated quantification of epicardial adipose tissue on CCTA via deep-learning detection of the pericardium: clinical implications

 Obesity

 Overweight, obesity, and abdominal adiposity

Banner-Guidelines-App-2024-970x90.jpg

 

 

This programme is supported by Novo Nordisk in the form of unrestricted financial support.
The scientific programme has not been influenced in any way by its sponsor.

Novo Nordisk A/S